Is there a well-tested tool to detect drug-seeking behaviors in chronic pain patients? by Gianutsos, L. Paul & Safranek, Sarah
CLINICAL INQUIRIES Evidence Based Answers from the Family Physicians 
Inquiries Network
 VOL 57, NO 9 / SEPTEMBER 2008 609www.jfponline.com
FAST TRACK
  
Is there a well-tested tool to 
detect drug-seeking behaviors 
in chronic pain patients?
No well-tested, 
easily administered 
screening tool 
exists for detecting 
drug-seeking 
behaviors in 
primary care 
patients
Clinical commentary
Consider the “5 As” approach
No gold standard defi nes the potential for 
addiction. This Clinical Inquiry shows the 
limitations of the available scoring methods 
for primary care. 
 A methodical approach can aid in 
initial evaluation and long-term monitoring 
of patients with chronic pain. One that 
I’ve found useful is the “5 As”—Analgesia, 
Affect, Activities of daily life, Adverse effects, 
and Aberrant behaviors.1 This approach 
makes chart review easy over multiple visits 
and provides meaningful information about 
the patient’s progress (or lack thereof). 
Once I’ve identifi ed potential drug-seeking 
behavior, I can determine how to respond. 
Tim Huber, MD
Oroville, Calif
❚ Evidence summary
Drug-seeking behaviors—known as 
aberrant behaviors in chronic pain lit-
erature—may suggest a substance abuse 
disorder (TABLE).2 At least 4 validated 
screening tools are available for predict-
ing or monitoring aberrant behaviors 
in patients with chronic, nonmalignant 
pain disorders who are being considered 
for, or receiving, opioid therapy:
The Screener and Opioid Assessment 
for Patients with Pain (SOAPP-R) is a 24-
item, self-administered questionnaire that 
stratifi es patients being considered for opi-
oid therapy into lower or higher risk for 
future opioid-related aberrant behaviors.2 
Each item queries frequency of behaviors 
and emotions consistent with opioid mis-
use and can be scored as 0 (never) to 4 
(very often). The items on the SOAPP-R 
were developed by a consensus panel of 
pain and addiction experts. 
In a multidisciplinary pain center 
study, the SOAPP-R was administered 
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Evidence-based answer
No, there is no well-tested, easily 
administered screening tool to detect 
drug-seeking behaviors in primary care 
patients taking long-term opioids or being 
considered for such therapy (strength 
of recommendation [SOR]: C, studies of 
intermediate outcomes). Several tools have 
undergone preliminary testing in pain centers 
and are being tested in different settings with 
larger numbers of patients. 
 For primary care providers, a useful 
screening tool for predicting drug-
seeking behaviors is the Screener and 
Opioid Assessment for Patients with Pain 
(SOAPP-R; SOR: C, studies of intermediate 
outcomes). Drug-seeking behavior in 
patients on long-term opioid therapy can be 
monitored with the Current Opioid Misuse 
Measure (COMM; SOR: C, studies of 
intermediate outcomes).
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to 283 chronic pain patients who were 
followed for 5 months. At a cutoff score 
of ≥18, the test had a positive likelihood 
ratio (LR+) of 3.80 and a negative like-
lihood ratio (LR−) of 0.29 for detect-
ing opioid misuse. At this cutoff, the 
SOAPP-R was 81% sensitive and 68% 
specifi c for predicting patients at high 
risk for aberrant behavior. 
The Opioid Risk Tool (ORT) is a self-
administered, 5-item questionnaire used 
to predict and monitor aberrant behav-
ior.3 Potential scores range from 0 to 26. 
When administered to 185 consecutive 
new patients at a chronic pain clinic, a 
score of <4 had an LR− of 0.08 and a 
score of ≥8 had an LR+ of 14 for mani-
festing opioid-related aberrant behav-
iors. Some ORT scoring criteria have 
not shown consistent results in other 
studies.4
The Current Opioid Misuse Measure 
(COMM) is used to monitor aberrant be-
haviors in patients on opioid therapy.5 
Scoring for the 17-item, self-adminis-
tered test is similar to the SOAPP-R. In 
a study of 86 patients at a multidisci-
plinary pain center, a score of ≥9 detect-
ed opioid misuse with an LR− of 0.08 
and an LR+ of 3.48, at a sensitivity of 
77% and specifi city of 66%. 
The Addiction Behaviors Checklist 
(ABC) is a 20-item Yes or No question-
naire administered by staff.6 At a cutoff 
score of 3 positive items, it had a sensi-
tivity of 88% and specifi city of 86% for 
detecting opioid misuse in 136 consecu-
tive patients at a multidisciplinary pain 
center.
Limitations of the studies
These studies have several limitations. 
The investigators who validated or eval-
uated the SOAPP-R and ORT included 
only patients at chronic pain clinics, so 
the instruments may not be applicable 
to patients in primary care settings2-4; 
the ORT study lacked standard mea-
sures of addiction3; and the ABC was 
tested in a population that was predom-
inantly male.6
Recommendations
A 2006 guideline of the American Soci-
ety of Interventional Pain Physicians de-
scribes behaviors that suggest abuse or 
misuse of opioid medication.7 These be-
haviors, which are similar to those listed 
in the TABLE, include failure to experience 
pain relief from high-dose opioids, lying 
to obtain opioids, obtaining drugs from 
multiple prescribers, functional dete-
rioration or lack of functional improve-
ment, exaggerating pain, and forgery. 
The guideline recommends monitoring 
patients for such behaviors. ■
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Selling prescription drugs
Forging prescriptions
Stealing drugs
Using oral formulations intranasally or by injection
Obtaining drugs from nonmedical sources
Concurrently abusing alcohol or other drugs
Functional deterioration
Unsanctioned dose escalations
Frequently reporting medications lost or stolen 
Seeking prescriptions from multiple prescribers
Red ﬂ ags for a substance abuse disorder
TABLE
The SOAPP and 
COMM instruments 
may help predict 
and monitor drug-
seeking behavior, 
respectively 
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